On November 13, Carol Schleif, BMO private wealth chief market strategist, joined ‘Squawk Box’ on CNBC to discuss the latest market trends, state of the economy, and takeaways from earnings season. Discussing the financial markets, Schleif confirmed that the market wants to trend to the upside and offered a fundamental market principle: new highs tend to beget new highs. She also provided two crucial points regarding valuations: valuations do not kill bull markets nor do they revive bear markets, and they can stay over- or undervalued for longer than typical fundamentals might suggest.
She then pivoted to the important underlying fundamentals that support the economy and the market in the intermediate and long term. This support was evident in the recent strong earnings season. With roughly 90% of results reported, Schleif cited an average of 8% top-line growth and 12% bottom-line growth, which shows that companies are actively growing profitability.
Earlier on October 28, Mark Sebastian, founder of Option Pit and Karman Line Capital, joined BNN Bloomberg to discuss the latest moves in the S&P 500 amid new all-time highs in the stock market. Sebastian affirmed that the S&P 500 is absolutely experiencing big swings. He explained that over the last couple of weeks, the S&P’s movement has indicated that options on US markets are probably too inexpensive.
That being said, we’re here with a list of the 10 cheap US stocks to buy according to analysts.
Our Methodology
We first sifted through the Finviz stock screener to compile a list of cheap US stocks that had a forward P/E ratio under 15. We then selected the 10 stocks that were the most popular among elite hedge funds and had an upside potential of over 45%. The stocks are ranked in ascending order of their upside potential. We have also added the hedge fund sentiment for each stock, as of Q2 2025.
Note: All data was sourced on November 18.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
10 Cheap US Stocks to Buy According to Analysts
10. Charter Communications Inc. (NASDAQ:CHTR)
Forward P/E Ratio as of November 18: 4.65
Number of Hedge Fund Holders: 56
Average Upside Potential as of November 18: 46.99%
Charter Communications Inc. (NASDAQ:CHTR) is one of the cheap US stocks to buy according to analysts. On November 4, Oppenheimer downgraded Charter to Perform from Outperform and removed the firm’s $500 price target. Oppenheimer has issued a cautious outlook on Charter Communications, due to several financial and operational concerns. The firm noted that in Q3 2025, Charter’s revenue saw a slight year-over-year decline of 0.9% to $13.7 billion. While Oppenheimer acknowledges that Charter’s new video strategy is successful, leading to demonstrably better sub trends, this positive performance is being overshadowed by a broader, persistent decline in its core broadband customer base.
In its Q3 earnings report, Charter Communications reported that its revenue for the quarter declined due to customer attrition and a difficult comparison with the previous year’s political advertising revenue. Similarly, EBITDA decreased by 1.5% year-over-year, although it was flat when the effect of advertising revenue was excluded. The company’s net income was $1.1 billion, a decrease from $1.3 billion reported in the same quarter last year.
However, Charter showed positive momentum in its mobile and video segments. The company added 493,000 Spectrum Mobile lines, contributing to a ~20% year-over-year increase in total mobile lines. Video customer losses improved, with a decline of only 70,000 customers, which is a substantial improvement compared to the loss of 294,000 video customers in the prior year. This was attributed to product improvements and new pricing/packaging.
Charter Communications Inc. (NASDAQ:CHTR) operates as a broadband connectivity and cable operator company serving residential and commercial customers in the US.
9. SharkNinja Inc. (NYSE:SN)
Forward P/E Ratio as of November 18: 14.33
Number of Hedge Fund Holders: 65
Average Upside Potential as of November 18: 54.90%
SharkNinja Inc. (NYSE:SN) is one of the cheap US stocks to buy according to analysts. On November 7, Canaccord analyst Brian McNamara raised the firm’s price target on SharkNinja to $138 from $136 and kept a Buy rating on the shares. Despite a struggling US market, the company reported a strong Q3 2025. This performance, combined with an optimistic outlook for Q4, coming from the excitement for the holiday season, led the firm to raise its 2025 financial guidance once again.
In its Q3 earnings report, SharkNinja achieved a 14.3% year-over-year increase in net sales, which totaled $1.63 billion. This performance marks the 10th consecutive quarter of double-digit organic growth for the company, which was supported by the company’s international segments.
The international sales alone surged by 25.8% to reach $530 million, primarily from the UK and Mexico. New product launches, such as the Shark FacialPro Glow, were also cited as major drivers of exceptional consumer engagement. Looking ahead, SharkNinja forecasts a 16% net sales growth for Q4.
SharkNinja Inc. (NYSE:SN) is a product design and technology company that provides various solutions for consumers in the US, China, and internationally.
8. Kyndryl Holdings Inc. (NYSE:KD)
Forward P/E Ratio as of November 18: 10.74
Number of Hedge Fund Holders: 36
Average Upside Potential as of November 18: 58.76%
Kyndryl Holdings Inc. (NYSE:KD) is one of the cheap US stocks to buy according to analysts. On November 18, Kyndryl announced the expansion of its collaboration with Dow (NYSE:DOW), which is a global leader in materials science. The expanded agreement focuses on modernizing Dow’s infrastructure applications by using AI and automation to enhance operational agility and accelerate innovation across Dow’s technology stack.
The collaboration builds on a relationship that has spanned ~2 decades, during which Kyndryl has enabled Dow to modernize and enhance operational efficiency across its global operations. Kyndryl also manages and provides Kyndryl Consult services for Dow’s IT infrastructure, including cloud, network, digital workplace, and security and resiliency services.
The new phase, however, specifically focuses on application modernization. Enterprise Applications & Technology IT Director at Dow, Chris Koniecny, noted that partnering with Kyndryl modernizes Dow’s application landscape and infuses AI and automation, which is a step forward in Dow’s digital transformation journey.
Kyndryl Holdings Inc. (NYSE:KD) operates as a technology services company and IT infrastructure services provider in the US, Japan, and internationally.
7. Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH)
Forward P/E Ratio as of November 18: 6.95
Number of Hedge Fund Holders: 45
Average Upside Potential as of November 18: 68.16%
Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) is one of the cheap US stocks to buy according to analysts. On November 18, Wells Fargo analyst Trey Bowers initiated coverage of Norwegian Cruise Line with an Overweight rating with a price target of $30. This sentiment was announced as Bowers believes that the company is positioned to achieve sustained double-digit earnings growth over the next several years.
After the release of the company’s Q3 2025 earnings report, the company’s share price declined. Wells Fargo considers this decline a favorable buying opportunity for investors.
In the Q3 earnings report, the company set a record for the highest quarterly revenue, which was driven by robust consumer demand. This revenue totaled $2.94 billion, growing by 4.69% year-over-year. The company’s bottom-line results exceeded guidance, and adjusted EPS came in at $1.20, which was $0.06 higher than the guidance.
Norwegian Cruise Line focused on attracting more families, which contributed to the higher load factors, but this shift led to some dilution in blended pricing due to more children in cabins. Building on this momentum, the company also raised its full-year adjusted EPS guidance to $2.10, which is a 19% year-over-year increase.
Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. It operates the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands.
6. The Chemours Company (NYSE:CC)
Forward P/E Ratio as of November 18: 5.52
Number of Hedge Fund Holders: 48
Average Upside Potential as of November 18: 69.26%
The Chemours Company (NYSE:CC) is one of the cheap US stocks to buy according to analysts. On November 10, RBC Capital analyst Arun Viswanathan lowered the firm’s price target on Chemours to $17 from $19 and kept an Outperform rating on the shares after the company saw Q3 2025 earnings miss. Viswanathan noted that the persistent pricing pressure within the TiO2 segment is a major drag for the company. Furthermore, operational setbacks in the Advanced Performance Materials division are currently offsetting the strong financial gains achieved by the Thermal & Specialized Solutions segment.
While these factors have contributed to an overall decline in Chemours’ stock value, the company’s Q3 2025 earnings report showed a strong quarter with performance that exceeded Adjusted EBITDA expectations, largely driven by the Thermal & Specialized Solutions segment. The company’s flagship Opteon refrigerants achieved a Q3 sales record, posting an impressive 80% year-over-year increase in sales.
The company recorded $1.50 billion in net sales for Q3. However, this was a modest 0.40% decline year-over-year. For Q4 and the full year 2025 as well, Chemours anticipates a decrease in net sales and consolidated adjusted EBITDA due to seasonality and market conditions. Consolidated adjusted EBITDA is expected to range between $130 and $160 million for the fourth quarter. Full year 2025 sales are anticipated to range between $5.7 and $5.8 billion.
The Chemours Company (NYSE:CC) provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.
5. BellRing Brands Inc. (NYSE:BRBR)
Forward P/E Ratio as of November 18: 11.36
Number of Hedge Fund Holders: 45
Average Upside Potential as of November 18: 71.36%
BellRing Brands Inc. (NYSE:BRBR) is one of the cheap US stocks to buy according to analysts. On November 19, Barclays analyst Andrew Lazar lowered the price target on BellRing Brands to $32 from $44 and maintained an Overweight rating on the shares. This sentiment was posted as Barclays updated the company’s model post the fiscal Q4 2024 report.
BellRing Brands concluded a strong FY2025, with a 16% year-over-year increase in net sales. For the fourth quarter alone, the company made $648.20 million in revenue, which was a 17% year-over-year rise. This success was driven by effective commercial execution, including the launch of its first media campaign since 2021, which delivered compelling returns and expanded distribution.
The flagship Premier Protein brand saw Q4 net sales growth of 15%, contributing to a 14% growth in the ready-to-drink shake sales, where consumption grew by 20%. Looking ahead, BellRing Brands provided FY2026 Net Sales Guidance projecting growth between 4% to 8%. The company acknowledged a potentially softer Q1 in fiscal 2026 due to specific dynamics but expects acceleration thereafter.
BellRing Brands Inc. (NYSE:BRBR) provides various nutrition products in the US. The company offers ready-to-drink/RTD protein shakes, other RTD beverages, protein powders, nutrition bars, and other products primarily under the Premier Protein and Dymatize brands.
4. Acadia Healthcare Company Inc. (NASDAQ:ACHC)
Forward P/E Ratio as of November 18: 7.09
Number of Hedge Fund Holders: 39
Average Upside Potential as of November 18: 86.54%
Acadia Healthcare Company Inc. (NASDAQ:ACHC) is one of the cheap US stocks to buy according to analysts. On November 18, KeyBanc lowered the firm’s price target on Acadia Healthcare to $30 from $35, while maintaining an Overweight rating on the shares. This sentiment was posted as KeyBanc cited the company’s Q3 2025 results and updated guidance.
In its Q3 2025 earnings report, Acadia Healthcare reported a 4.4% increase in revenue for the quarter, which totaled $851.6 million. This was supported by initiatives, such as a 3% same facility admissions growth driven by targeted improvements in acute care referral sources. The company also earned $0.72 per share, which also beat estimates by $0.06.
However, the company’s adjusted EBITDA for Q3 fell to $173 million from $194.3 million in the prior year period, primarily due to softer-than-expected volumes in the Medicaid business and increased payer friction. Consequently, Acadia was compelled to reduce its Adjusted EBITDA guidance for 2025 to a range of $650 to $660 million, down from the previously issued guidance of $675 to $700 million.
Acadia Healthcare Company Inc. (NASDAQ:ACHC) provides behavioral healthcare services in the US and Puerto Rico.
3. Five9 Inc. (NASDAQ:FIVN)
Forward P/E Ratio as of November 18: 5.85
Number of Hedge Fund Holders: 40
Average Upside Potential as of November 18: 88.27%
Five9 Inc. (NASDAQ:FIVN) is one of the cheap US stocks to buy according to analysts. On November 18, Five9 introduced a powerful suite of AI-powered innovations at the Five9 CX Summit 2025. These new capabilities extend the Five9 Genius AI suite, integrating AI across routing, quality management, and analytics to create a more unified ecosystem.
This move is designed to help organizations accelerate their move from AI pilot programs to enterprise-scale utilization and elevate every customer interaction. The innovations directly address common challenges in AI adoption, such as fragmented systems, siloed data, and difficulty in measuring ROI. By positioning AI as a connective layer, Five9 aims to foster more integrated operations and strengthen customer connections at scale, aligning with their Agentic CX vision.
Five9 introduced several specific AI-powered capabilities. Agentic Quality Management/AQM is a next-gen solution that can evaluate up to 100% of customer interactions. Genius Routing is a dynamic matching engine using an API-driven design that assists in connecting customers to agents based on real-time inputs. OneVUE is a unified, self-service reporting and analytics application that builds on the capabilities of the previously offered Aceyus VUE.
Five9 Inc. (NASDAQ:FIVN) provides intelligent cloud software for contact centers in the US and internationally. It offers a CX platform that delivers a suite of applications, which enables the breadth of customer service, sales, and marketing functions.
2. Stride Inc. (NYSE:LRN)
Forward P/E Ratio as of November 18: 8.42
Number of Hedge Fund Holders: 41
Average Upside Potential as of November 18: 93.59%
Stride Inc. (NYSE:LRN) is one of the cheap US stocks to buy according to analysts. On November 7, BMO Capital lowered the firm’s price target on Stride to $82 from $108, while keeping a Market Perform rating on the shares. This sentiment was posted when the company’s stock experienced a sell-off following the disclosure of a failed platform integration. However, BMO Capital noted that the company has avoided receiving non-renewal notices from its partners regarding this issue, attributing this stability to the goodwill it has established with these organizations.
In its FQ1 2026 earnings report, Stride reported strong financial growth that was partially overshadowed by operational issues due to a failed technology platform integration. While the rationale for the upgrade was to invest in platforms to support future scale, the implementation of both a front-end learning platform and a back-office administrative platform did not go smoothly, especially at the start of August 2025. Still, the company was able to generate $620.9 million, which was up 13% year-over-year, driven by strong demand that led to record enrollment growth and an increase in revenue per student.
The negative impact on enrollment was substantial: the company estimates that the platform implementation issues, combined with constraints on intake, led to ~10,000 to 15,000 fewer enrollments than what could have otherwise been achieved. Total enrollments for the quarter still grew by 11.3% from the prior year. Still, the company’s revenue increased by 13% year-over-year and reached $620.9 million, fueled by the Career Learning segment, where revenue was $241.5 million, up 21%.
Stride Inc. (NYSE:LRN) provides proprietary and third-party online curriculum, software systems, and educational services in the US and internationally.
1. Soleno Therapeutics Inc. (NASDAQ:SLNO)
Forward P/E Ratio as of November 18: 9.76
Number of Hedge Fund Holders: 52
Average Upside Potential as of November 18: 147.22%
Soleno Therapeutics Inc. (NASDAQ:SLNO) is one of the cheap US stocks to buy according to analysts. On November 18, Wolfe Research analyst Kalpit Patel initiated coverage of Soleno Therapeutics with an Outperform rating and $75 price target. The company’s shares showed recent weakness in the market due to a sequential slowing in the number of new patient starts. However, Patel noted that the market’s safety concerns surrounding this slowdown are considered overblown.
Based on the firm’s proprietary survey results, Patel maintains that the overall directional trend for patient utilization is highly favorable and is expected to continue for the next 1-2 years. This market outlook also aligns with the strong financial results recently reported by the company.
In its Q3 2025 earnings report, Soleno Therapeutics reported a positive net income of $26 million, driven by sharply increased sales of its drug, ViCAT XR. Total net revenue more than doubled from Q2 and reached $66 million. The growing market adoption of ViCAT XR is reflected by the fact that the company has secured broad coverage, encompassing ~132 million lives, and currently has 764 active patients on the drug, all of whom have claims being reimbursed.
Soleno Therapeutics Inc. (NASDAQ:SLNO) is a clinical-stage biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of rare diseases.
While we acknowledge the potential of SLNO to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SLNO and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
